Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Ovarian Cancer Clinical Trial

Official title:

A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01267851
• Other study ID #: GM2010-06-02
• Status: Recruiting
• Start date: January 1, 2010
• Est. completion date: December 30, 2020

Study information

• Verified date: July 2019
• Source: Huazhong University of Science and Technology
• Contact: Ma Ding, M.D.
• Phone: 86-27-8362681
• Email: dma[@]tjh.tjmu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Description:

The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.

The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1600000
• Est. completion date: December 30, 2020
• Est. primary completion date: December 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• patients with informed consent;

• patients with gynecologic diseases;

• patients with intact clinical and pathological information

Exclusion Criteria:

• not included in the inclusion criteria

Related Conditions & MeSH terms

• Cervical Cancer
• Choriocarcinoma
• Endometrial Cancer
• Endometrial Neoplasms
• Endometriosis
• Genital Neoplasms, Female
• Leiomyoma
• Neoplasms
• Ovarian Cancer
• Uterine Cervical Neoplasms
• Uterine Myoma

Locations

Country	Name	City	State
China	Tongji Hospital of HUST	Wuhan	Hubei

Sponsors (10)

Lead Sponsor	Collaborator
Huazhong University of Science and Technology	First Affiliated Hospital Xi'an Jiaotong University, Guangxi Medical University, Hunan Province Tumor Hospital, Obstetrics & Gynecology Hospital of Fudan University, Peking University People's Hospital, Shanghai First Maternity and Infant Hospital, The Central Hospital of Wuhan, West China Second University Hospital, Zhejiang University

Country where clinical trial is conducted

China,